Growth Metrics

Opus Genetics (IRD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Opus Genetics 357.99 Mn 298.03 Mn - 233.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 233.82%
Dec 31, 2025 221.29%
Sep 30, 2025 211.71%
Jun 30, 2025 204.56%
Mar 31, 2025 198.34%
Dec 31, 2024 193.18%
Sep 30, 2023 -60.52%
Jun 30, 2023 -58.83%
Mar 31, 2023 -57.80%
Dec 31, 2022 -35.15%
Sep 30, 2022 -56.54%
Jun 30, 2022 -56.12%
Mar 31, 2022 -55.04%
Dec 31, 2021 -55.37%
Sep 30, 2021 -55.34%
Jun 30, 2021 -50.30%
Mar 31, 2021 -50.83%
Dec 31, 2020 -51.33%
Sep 30, 2020 -14.88%
Jun 30, 2020 -12.86%
Mar 31, 2020 -7.37%
Dec 31, 2019 -37.16%
Sep 30, 2019 -4.21%
Jun 30, 2019 -3.50%
Mar 31, 2019 -3.83%
Dec 31, 2018 -0.13%
Sep 30, 2018 3.72%
Jun 30, 2018 7.89%
Mar 31, 2018 11.05%
Dec 31, 2017 15.86%
Sep 30, 2017 2.74%
Jun 30, 2017 12.57%
Mar 31, 2017 11.79%
Dec 31, 2016 10.80%
Sep 30, 2016 11.28%
Jun 30, 2016 44.10%
Mar 31, 2016 36.84%
Dec 31, 2015 29.36%
Sep 30, 2015 21.05%
Jun 30, 2015 2.12%
Mar 31, 2015 -1.60%
Dec 31, 2014 -6.17%
Sep 30, 2014 -7.82%
Jun 30, 2014 -15.59%
Dec 31, 2013 -19.20%